Synaptogenix Inc

Company Profile

Synaptogenix Inc had its IPO on 2020-12-08 under the ticker symbol SNPX.

The company operates in the Healthcare sector and Biotechnology industry. Synaptogenix Inc has a staff strength of 5 employees.

Stock update

Shares of Synaptogenix Inc opened at $0.34 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.33 - $0.36, and closed at $0.36.

This is a +4.66% increase from the previous day's closing price.

A total volume of 610,441 shares were traded at the close of the day’s session.

In the last one week, shares of Synaptogenix Inc have slipped by -29.61%.

Synaptogenix Inc's Key Ratios

Synaptogenix Inc has a market cap of $4.68 million, indicating a price to book ratio of 1.4396 and a price to sales ratio of 0.

In the last 12-months Synaptogenix Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-13801296. The EBITDA ratio measures Synaptogenix Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Synaptogenix Inc’s operating margin was 0% while its return on assets stood at -27.39% with a return of equity of -16.17%.

In Q2, Synaptogenix Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Synaptogenix Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.44 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Synaptogenix Inc’s profitability.

Synaptogenix Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.8325. Its price to sales ratio in the trailing 12-months stood at 0.

Synaptogenix Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$33.44 million

Total Liabilities

$2.77 million

Operating Cash Flow

$0

Capital Expenditure

$669

Dividend Payout Ratio

0%

Synaptogenix Inc ended 2024 with $33.44 million in total assets and $0 in total liabilities. Its intangible assets were valued at $33.44 million while shareholder equity stood at $26.91 million.

Synaptogenix Inc ended 2024 with $0 in deferred long-term liabilities, $2.77 million in other current liabilities, 738.00 in common stock, $-32019904.00 in retained earnings and $0 in goodwill. Its cash balance stood at $32.90 million and cash and short-term investments were $32.90 million. The company’s total short-term debt was $2,265,375 while long-term debt stood at $0.

Synaptogenix Inc’s total current assets stands at $33.42 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $439147.00 and inventory worth $0.

In 2024, Synaptogenix Inc's operating cash flow was $0 while its capital expenditure stood at $669.

Comparatively, Synaptogenix Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.36

52-Week High

$8.43

52-Week Low

$0.33

Analyst Target Price

$14

Synaptogenix Inc stock is currently trading at $0.36 per share. It touched a 52-week high of $8.43 and a 52-week low of $8.43. Analysts tracking the stock have a 12-month average target price of $14.

Its 50-day moving average was $0.67 and 200-day moving average was $1.27 The short ratio stood at 0.76 indicating a short percent outstanding of 0%.

Around 962.7% of the company’s stock are held by insiders while 368.7% are held by institutions.